mRNA Vaccine Creator “They Were Aware” of Risks with Spike Protein

ck when we were doing randomized clinical trials that these adverse events were occurring, many of them were oddly delayed and atypical for a vaccine trial. This is totally new technology and that kind of gets at the core is I think one of our problems here is the assumption that this is like every other vaccine we have ever seen and it’s not. It’s very different technology.”